Iovance Biotherapeutics
IOVA
#5408
Rank
โ‚น84.08 B
Marketcap
โ‚น256.45
Share price
-7.69%
Change (1 day)
-77.25%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2024 (TTM): -โ‚น33.2 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are โ‚น0.16 Billion. , an increase over its 2023 earnings that were of -โ‚น39.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚น33.79 Billion-14.17%
2023 -โ‚น39.37 Billion15.46%
2022 -โ‚น34.1 Billion16.39%
2021 -โ‚น29.3 Billion30.83%
2020 -โ‚น22.4 Billion26.62%
2019 -โ‚น17.69 Billion61.29%
2018 -โ‚น10.97 Billion38.09%
2017 -โ‚น7.94 Billion73.16%
2016 -โ‚น4.59 Billion92.7%
2015 -โ‚น2.38 Billion131.17%
2014 -โ‚น1.03 Billion-51.71%
2013 -โ‚น2.14 Billion6291.81%
2012 -โ‚น33.35 Million
2008 -โ‚น4.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น3.01 B-108.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น0.19 Billion-99.45% Bahamas